Search alternatives:
non decrease » point decrease (Expand Search), note decreased (Expand Search), fold decrease (Expand Search)
we decrease » _ decrease (Expand Search), mean decrease (Expand Search), teer decrease (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
non decrease » point decrease (Expand Search), note decreased (Expand Search), fold decrease (Expand Search)
we decrease » _ decrease (Expand Search), mean decrease (Expand Search), teer decrease (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
1061
-
1062
-
1063
-
1064
-
1065
-
1066
-
1067
-
1068
-
1069
-
1070
-
1071
-
1072
DataSheet_1_Preclinical characterization of amubarvimab and romlusevimab, a pair of non-competing neutralizing monoclonal antibody cocktail, against SARS-CoV-2.pdf
Published 2022“…In a Syrian golden hamster model of SARS-CoV-2 infection, animals receiving combination of amubarvimab and romlusevimab either pre- or post-infection demonstrated less weight loss, significantly decreased viral load in the lungs, and reduced lung pathology compared to controls. …”
-
1073
Native A1AT effect on efferocytosis receptors expression and ADAM-17 (TACE) activity in CS-exposed AM.
Published 2017“…<b>D.</b> A1AT treatment (Prolastin C, 100 μg/mL) time-dependently decreases TACE activity in the CS-exposed (10%, 4 h) THP-1 membrane fraction. …”
-
1074
Iron(III) Complexes of Tripodal Monophenolate Ligands as Models for Non-Heme Catechol Dioxygenase Enzymes: Correlation of Dioxygenase Activity with Ligand Stereoelectronic Properti...
Published 2009“…Also, when the substituents on the phenolate arm are varied to tune the Lewis acidity of iron(III) center, the reaction rate decreases with decrease in Lewis acidity and, interestingly, extradiol cleavage is also observed when the Lewis acidity is decreased further by incorporating a 3,5-dimethylphenolate arm as in <b>6</b>.…”
-
1075
-
1076
-
1077
Design and analysis of PV fed high-voltage gain DC-DC converter using PI and NN controllers
Published 2022“…When the converter switch comes under active state two capacitors are discharged in series, similarly when the converter switch under inactive state those two capacitors are charged in parallel through the coupled inductor (CI) energy so, to get a high voltage at the converter output side. To reuse the leakage-inductor (LI) energy of the CI with the help of a passive clamp circuit for reducing the voltage stress across the switch, similarly switch has less resistance so conduction losses also decreased. …”
Get full text
Get full text
Get full text
article -
1078
Controlling the Temperature and Speed of the Phase Transition of VO<sub>2</sub> Microcrystals
Published 2016“…The phase transition speed increases from 4.6 × 10<sup>2</sup> to 1.7 × 10<sup>4</sup> μm/s as the width decreases from ∼50 to ∼2 μm. While the statistical description for a heterogeneous nucleation process explains the size dependence on phase transition temperature of VO<sub>2</sub>, the increase of effective thermal exchange process is responsible for the enhancement of phase transition speed of small VO<sub>2</sub> microcrystals. …”
-
1079
Different response of visASCs to a micro-local oxygen concentration decrease in metabolically active sites of the adipose tissue.
Published 2017“…However, hypox-visASCs from MS patients show a lower ability to actively participate in or stimulate the formation of microvascular structures, while they favor the accumulation of CD11C<sup>+</sup> and CD163<sup>+</sup> macrophages in the adipose tissue through their contribution to the increased tissue levels of MCP1. ↑ Increased response; <b>↓</b> Decreased response; → Hypox-visASCs main response NonMS: obese subjects without metabolic syndrome; MS: obese subjects with metabolic syndrome; visASC: visceral adipose tissue-derived multipotent mesenchymal cells; hypox-visASCs: visASC under hypoxia; NOX5: NADPH Oxidase 5; SDF1α: stromal cell-derived factor 1α; VEGF: vascular endothelial growth factor; MCP1: monocyte chemoattractant protein 1; CD11C<sup>+</sup>, CD163<sup>+</sup>: proinflammatory macrophage cell-surface markers.…”
-
1080